SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-014133
Filing Date
2020-07-29
Accepted
2020-07-29 08:21:43
Documents
5
Period of Report
2020-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 48398
2 ex4-1.htm EX-4.1 119631
3 ex10-1.htm EX-10.1 842911
4 ex99-1.htm EX-99.1 26121
5 ex99-1_001.jpg GRAPHIC 44689
  Complete submission text file 0001493152-20-014133.txt   1100179
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 201055839
SIC: 2834 Pharmaceutical Preparations